Patiromer for treating hyperkalaemia- technology appraisal guidance (TA623)

NICE recommends use in adults only if used in emergency care for acute life-threatening hyperkalaemia (HK) alongside standard care or for people with persistent HK and stages 3b to 5 CKD or heart failure, if their serum potassium ≥6.0 mmol/L and they satisfy other criteria.


National Institute for Health and Care Excellence